DESIGN AND DEVELOPMENT OF SIMVASTATIN GASTRORETENTIVE TABLETS FOR CONTROLLED RELEASE

Journal Title: Journal of Drug Delivery and Therapeutics - Year 2017, Vol 7, Issue 1

Abstract

Simvastatin is a Hypolipidemic used to control elevated cholesterol or hypercholesterolemia. The primary uses of simvastatin are for the treatment of dyslipidemia and the prevention of cardiovascular disease. Gastroretentive Floating tablets of Simvastatin were developed by direct compression method using HPMC K15M, HPMC K100M, Carbopol, sodium CMC, xanthan gum, sodium alginate polymers used and the mixture of the sodium bicarbonate, citric acid anhydrous as gas generating agents. The results of Pre-compressional and post compression parameters were within IP prescribed limits. The formulation FC1, FC2, FC3, FC4, FC5, FC6, FC8 floated but the lag time was more and floating time is less. For the formulation FC7, the duration of buoyancy was more than 12 hrs, the floating capacity increased in these formulations and floated with less lag time due to the high concentration of gas generating agent sodium bicarbonate-induced CO2 generation in the pressure of dissolution medium (pH 1.2 0.1N HCL). The drug release from the formulations FC1-FC8 was found to be 78.612, 72.66, 87.22, 63.45, 67.26, 73.24, 98.93, and 81.27 in 12hrs. Among all the formulations FC7 floating lag time 7 min with 99% of drug release has better control release of the drug. DSC and FTIR studies revealed that there was no incompatibility of the drug with the excipients used. The stability study conducted as per the ICH guidelines and the formulations were found to be stable. From this study, it can be concluded that the formulation retained for longer periods of time in the stomach and provides controlled release of the drug and may improve bioavailability.

Authors and Affiliations

NG Raghavendra Rao

Keywords

Related Articles

Study to assess the health issues among employees working in selected call centres of Mangalore

Background: The new mantra for job opportunities among young population is “call center”. Though Bangalore is considered as hub for call centres, the slowly call centres are emerging in Mangalore. Since this job has got...

MANGIFERIN PROTECTS RENAL IMPAIRMENT AGAINST BENZO(A)PYRENE INDUCED TOXICITY BY REGULATING MITOCHONDRIAL AND DNA INTEGRITY

Contaminated food and water ingestion and inhalation of polycyclic aromatic hydrocarbon are the main sources of human exposure to benzo(a)pyrene leading to cause renal injury and provoking a nephropathic response. Mangif...

PREVALENCE OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN AYDER REFERRAL HOSPITAL, TIGRAY REGION, NORTHERN ETHIOPIA: PROSPECTIVE STUDY

Background: Potentially inappropriate medication (PIM) use includes the use of drugs with higher risk where adverse drug effect outweighs the clinical benefit, especially when more effective alternative therapy is availa...

FORMULATION AND EVALUATION OF TABLETS CONTAINING ARTEMETHER MICROSPHERES AND LUMEFANTRINE

This study was aimed to fabricate and evaluate a combination of Artemether and Lumefantrine as tablets and to make Artemether in sustained form so as to prolong its elimination time. Artemether was formulated in form of...

FORMULATION, EVALUATION AND OPTIMIZATION OF RANITIDINE HYDROCHLORIDE FLOATING TABLETS WITH IMPROVED GI ABSORPTION

Oral drug delivery system represents one of the main areas of sustained drug delivery system. Floating drug delivery system related to oral sustained drug delivery system group, which is capable of floating in the stomac...

Download PDF file
  • EP ID EP294087
  • DOI 10.22270/jddt.v7i1.1353
  • Views 118
  • Downloads 0

How To Cite

NG Raghavendra Rao (2017). DESIGN AND DEVELOPMENT OF SIMVASTATIN GASTRORETENTIVE TABLETS FOR CONTROLLED RELEASE. Journal of Drug Delivery and Therapeutics, 7(1), 30-36. https://europub.co.uk/articles/-A-294087